R Squared LTD Lexicon Pharmaceuticals, Inc. Transaction History

R Squared LTD

$181 Billion
Q2 2025

A detailed history of R Squared LTD transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, R Squared LTD holds 29,559 shares of LXRX stock, worth $33,992. This represents 0.02% of its overall portfolio holdings.

Number of Shares

29,559

Holding current value

$33,992

% of portfolio

0.02%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Jul 31, 2025	BUY	$0.42 - $0.95 $12,414 - $28,081	29,559 New	29,559 $28 Million
Q4 2024 Jan 22, 2025	BUY	$0.65 - $2.08 $1,976 - $6,323	3,040 New	3,040 $2.25 Million

Others Institutions Holding LXRX

# of Institutions

135

Shares Held

199M

Call Options Held

310K

Put Options Held

77.3K

Artal Group S.A. Luxembourg, N4

136M
Shares

$157 Million
100.0% of portfolio
Black Rock Inc. New York, NY

9.89M
Shares

$11.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

9.56M
Shares

$11 Million
0.0% of portfolio
Schonfeld Strategic Advisors LLC New York, NY

8.21M
Shares

$9.44 Million
0.03% of portfolio
Geode Capital Management, LLC Boston, MA

3.69M
Shares

$4.24 Million
0.0% of portfolio

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $217M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of R Squared LTD, based on Form 13F filings with the SEC.

News

Stay updated on R Squared LTD with notifications on news.

Account